Biao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Biao Li has a total of 582 co-authors. Here are the top co-authors by number of shared publications:
Rui Guo
33 shared publicationsMiao Zhang
Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
26 shared publicationsMin Zhang
24 shared publicationsYing Miao
22 shared publicationsXinyun Huang
Department of Nuclear Medicine & Institute for medical imaging technology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
20 shared publicationsHongping Meng
Department of Nuclear Medicine & Institute for medical imaging technology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
18 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Elsevier in Neurobiology of Disease
- Vol. 230, 107622
Convergence of spatially dispersed atrophy into functional networks in temporal lobe epilepsy: glial-immune signature associated with circuit dysfunction and treatment response
- 24 September 2026
- Published by Elsevier in Neurobiology of Disease
- Vol. 230, 107622
Open AccessConvergence of spatially dispersed atrophy into functional networks in temporal lobe epilepsy: glial-immune signature associated with circuit dysfunction and treatment response
- 15 September 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (13) , 8597-8609
Development and validation of a preoperative 18F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study
- 15 September 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (13) , 8597-8609
Development and validation of a preoperative 18F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study
- 22 August 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 114
Count-aware diffusion with autoregressive inference for low-count PET reconstruction enhancement
- 22 August 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 114
Count-aware diffusion with autoregressive inference for low-count PET reconstruction enhancement
- Open Access
- 19 June 2026
- Published by Elsevier in The EANM Journal
- Vol. 4
The 6th Chinese academic symposium on PET/MR: Updates of clinical practice and existing challenges
- 19 June 2026
- Published by Elsevier in The EANM Journal
- Vol. 4
Open AccessThe 6th Chinese academic symposium on PET/MR: Updates of clinical practice and existing challenges
- 27 May 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- p. 1-16
Optimized PET/CT response assessment for prognostic stratification compared with Lugano criteria in extranodal NK/T-Cell lymphoma
Purpose Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive malignancy and usually involves the nasal cavity. Although the Lugano criteria is widely used for lymphoma response assessment, its applicability in ENKTL is limited by reliance on a single pre-treatment reference and a positive reference threshold with high false-positive rate. This study proposed and evaluated the ability of a novel evaluation system derived from the Lugano criteria to predict ENKTL treatment response. Methods A total of 259 patients underwent baseline, interim, and end-of-treatment [18F]FDG PET/CT. Treatment responses were evaluated on PET/CT using the Lugano, IPET (with interim PET/CT as the reference time point), NPU (with nasal mucosal uptake as the positive reference), and IPN (with integration of interim PET/CT as the reference time point and nasal mucosal uptake as the positive reference) criteria. Endpoints were progression-free survival (PFS) and overall survival (OS). Cox regression analysis was used to assess prognostic factors, and model discrimination was quantified using Harrell’s concordance index (C-index). Results The three novel systems reclassified patients initially evaluated by Lugano. Reclassification from partial response or stable disease to a worse response category by IPET and IPN correlated with worse outcomes, whereas reclassification to complete response by NPU or IPN predicted improved outcomes. The IPN achieved the highest C-index for prediction of PFS and OS and remained independently associated with survival after multivariable adjustment. Conclusion The IPN, IPET, and NPU criteria were superior to the Lugano classification for prognostic stratification. The IPN criteria had the best prediction performance and allowed early identification of high-risk patients.
- 27 May 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- p. 1-16
Optimized PET/CT response assessment for prognostic stratification compared with Lugano criteria in extranodal NK/T-Cell lymphoma
Purpose Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive malignancy and usually involves the nasal cavity. Although the Lugano criteria is widely used for lymphoma response assessment, its applicability in ENKTL is limited by reliance on a single pre-treatment reference and a positive reference threshold with high false-positive rate. This study proposed and evaluated the ability of a novel evaluation system derived from the Lugano criteria to predict ENKTL treatment response. Methods A total of 259 patients underwent baseline, interim, and end-of-treatment [18F]FDG PET/CT. Treatment responses were evaluated on PET/CT using the Lugano, IPET (with interim PET/CT as the reference time point), NPU (with nasal mucosal uptake as the positive reference), and IPN (with integration of interim PET/CT as the reference time point and nasal mucosal uptake as the positive reference) criteria. Endpoints were progression-free survival (PFS) and overall survival (OS). Cox regression analysis was used to assess prognostic factors, and model discrimination was quantified using Harrell’s concordance index (C-index). Results The three novel systems reclassified patients initially evaluated by Lugano. Reclassification from partial response or stable disease to a worse response category by IPET and IPN correlated with worse outcomes, whereas reclassification to complete response by NPU or IPN predicted improved outcomes. The IPN achieved the highest C-index for prediction of PFS and OS and remained independently associated with survival after multivariable adjustment. Conclusion The IPN, IPET, and NPU criteria were superior to the Lugano classification for prognostic stratification. The IPN criteria had the best prediction performance and allowed early identification of high-risk patients.
- Open Access
- 16 May 2026
- Published by Elsevier in The EANM Journal
- Vol. 3
Proof of concept of anatomical independence in long axial field of view PET using AI-based CT-free multi-organ segmentation
- 16 May 2026
- Published by Elsevier in The EANM Journal
- Vol. 3
Open AccessProof of concept of anatomical independence in long axial field of view PET using AI-based CT-free multi-organ segmentation
- Open Access
- 14 May 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Generalizable CT-free PET attenuation and scatter correction via few-shot cross domain adaptation
The rapid advancements in PET technology, coupled with the need for accurate and efficient imaging, necessitate the development of robust and generalizable methods for CT-free attenuation and scatter correction (ASC). Deep learning offers a promising solution, but exhibits limited performance when tested in diverse clinical settings and varying imaging conditions. We propose a few-shot fine-tuning paradigm that enables efficient adaptation of models from a source domain to a new target domain. Our backbone network incorporates statistical modulation to extract domain-specific distribution information and employs pixel-wise factor scaling modeling to disentangle ASC factor maps from input images. On a large and diverse dataset of 1539 subjects across multiple tracers, scanners, and centers, we evaluate model performance under single-tracer training, multi-tracer joint training, and few-shot adaptation strategies. Although joint training demonstrates strong performance on known tracers, the proposed few-shot adaptation approach, CrossPET-Adapt, excels at adapting to unseen domains with minimal data, outperforming joint training. This method significantly reduces radiation exposure and data requirements, offering a rapid and robust solution for CT-free PET ASC in varied clinical environments.
- 14 May 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessGeneralizable CT-free PET attenuation and scatter correction via few-shot cross domain adaptation
The rapid advancements in PET technology, coupled with the need for accurate and efficient imaging, necessitate the development of robust and generalizable methods for CT-free attenuation and scatter correction (ASC). Deep learning offers a promising solution, but exhibits limited performance when tested in diverse clinical settings and varying imaging conditions. We propose a few-shot fine-tuning paradigm that enables efficient adaptation of models from a source domain to a new target domain. Our backbone network incorporates statistical modulation to extract domain-specific distribution information and employs pixel-wise factor scaling modeling to disentangle ASC factor maps from input images. On a large and diverse dataset of 1539 subjects across multiple tracers, scanners, and centers, we evaluate model performance under single-tracer training, multi-tracer joint training, and few-shot adaptation strategies. Although joint training demonstrates strong performance on known tracers, the proposed few-shot adaptation approach, CrossPET-Adapt, excels at adapting to unseen domains with minimal data, outperforming joint training. This method significantly reduces radiation exposure and data requirements, offering a rapid and robust solution for CT-free PET ASC in varied clinical environments.
- Open Access
- 1 May 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (5) , 367
A comparison of three-dimensional-ring CZT and NaI(Tl) single-photon emission computed tomography systems using 99mTc-methoxyisobutylisonitrile in patients with hyperparathyroidism, with concurrent phantom studies
Background: Previous research has shown that cadmium-zinc-telluride (CZT) crystals, as semiconductor detectors, provide higher spatial and energy resolution than thallium-activated sodium iodide [NaI(Tl)] crystals. This study aimed to evaluate the extent to which a full-ring CZT single-photon emission computed tomography/computed tomography (SPECT/CT) system could improve the image quality of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) parathyroid imaging, as well as its potential to enhance diagnostic accuracy and optimize imaging protocols. Methods: Two phantoms were acquired: (I) a uniform phantom to obtain the calibration factor; and (II) a National Electrical Manufacturers Association (NEMA) International Electrotechnical Commission (IEC) phantom containing different-sized spheres to compare the contrast-to-noise ratio (CNR) and recovery coefficients (RCs). A total of 85 patients who were diagnosed with hyperparathyroidism (HPT) were enrolled in this study. Two hours after injecting 99mTc-MIBI, delay-phase parathyroid scanning was performed sequentially on NaI(Tl) SPECT/CT in 8 minutes and full-ring CZT SPECT/CT in 6 minutes. List-mode data were used to reconstruct 3-minute CZT SPECT/CT images. A 10-mm diameter volume of interest (VOI) was used to delineate the lesion and reference regions. The coefficient of variation (CV) and CNR were calculated to quantitatively compare image quality and lesion contrast. The standardized uptake values (SUVs) of the lesions were calculated from the images acquired using the full-ring CZT SPECT/CT. Clinical and pathology information were collected through standardized pre-procedural medical history inquiry and subsequent patient follow-up. Results: The NaI(Tl) system exhibited a lower CNR than the full-ring CZT system when using the same injected activity and their respective recommended NEMA IEC phantom parameters. For the images acquired with the full-ring CZT system, those reconstructed using block sequential regularized expectation maximization (BSREM) 20i10s exhibited a higher CNR than those reconstructed using OSEM 4i10s. Compared with OSEM 20i10s, although the difference in the CNR was not statistically significant, the spheres appeared visually clearer, which may be attributed to a more uniform background (CV: OSEM 20i10s, 19.9%; BSREM 20i10s, 17.9%). In the clinical patients, all the three imaging conditions, including 8-minute NaI(Tl), 3-minute CZT, and 6-minute CZT imaging, identified the same positive lesions upon visual assessment. In the image quality comparison, the full-ring CZT system with the standard 6-minute imaging sequence demonstrated better performance than the NaI(Tl) system to varying degrees. Specifically, the CV was lower for the CZT system based on the thyroid (P=0.022) and mediastinal blood pool (PConclusions: The full-ring CZT SPECT/CT system exhibited a higher CNR than the NaI(Tl) crystal-based system in the delay-phase scan of 99mTc-MIBI parathyroid imaging when using the thyroid and mediastinal blood pool as references. Additionally, it enables acquisition within a reduced time frame while maintaining comparable diagnostic sensitivity.
- 1 May 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (5) , 367
Open AccessA comparison of three-dimensional-ring CZT and NaI(Tl) single-photon emission computed tomography systems using 99mTc-methoxyisobutylisonitrile in patients with hyperparathyroidism, with concurrent phantom studies
Background: Previous research has shown that cadmium-zinc-telluride (CZT) crystals, as semiconductor detectors, provide higher spatial and energy resolution than thallium-activated sodium iodide [NaI(Tl)] crystals. This study aimed to evaluate the extent to which a full-ring CZT single-photon emission computed tomography/computed tomography (SPECT/CT) system could improve the image quality of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) parathyroid imaging, as well as its potential to enhance diagnostic accuracy and optimize imaging protocols. Methods: Two phantoms were acquired: (I) a uniform phantom to obtain the calibration factor; and (II) a National Electrical Manufacturers Association (NEMA) International Electrotechnical Commission (IEC) phantom containing different-sized spheres to compare the contrast-to-noise ratio (CNR) and recovery coefficients (RCs). A total of 85 patients who were diagnosed with hyperparathyroidism (HPT) were enrolled in this study. Two hours after injecting 99mTc-MIBI, delay-phase parathyroid scanning was performed sequentially on NaI(Tl) SPECT/CT in 8 minutes and full-ring CZT SPECT/CT in 6 minutes. List-mode data were used to reconstruct 3-minute CZT SPECT/CT images. A 10-mm diameter volume of interest (VOI) was used to delineate the lesion and reference regions. The coefficient of variation (CV) and CNR were calculated to quantitatively compare image quality and lesion contrast. The standardized uptake values (SUVs) of the lesions were calculated from the images acquired using the full-ring CZT SPECT/CT. Clinical and pathology information were collected through standardized pre-procedural medical history inquiry and subsequent patient follow-up. Results: The NaI(Tl) system exhibited a lower CNR than the full-ring CZT system when using the same injected activity and their respective recommended NEMA IEC phantom parameters. For the images acquired with the full-ring CZT system, those reconstructed using block sequential regularized expectation maximization (BSREM) 20i10s exhibited a higher CNR than those reconstructed using OSEM 4i10s. Compared with OSEM 20i10s, although the difference in the CNR was not statistically significant, the spheres appeared visually clearer, which may be attributed to a more uniform background (CV: OSEM 20i10s, 19.9%; BSREM 20i10s, 17.9%). In the clinical patients, all the three imaging conditions, including 8-minute NaI(Tl), 3-minute CZT, and 6-minute CZT imaging, identified the same positive lesions upon visual assessment. In the image quality comparison, the full-ring CZT system with the standard 6-minute imaging sequence demonstrated better performance than the NaI(Tl) system to varying degrees. Specifically, the CV was lower for the CZT system based on the thyroid (P=0.022) and mediastinal blood pool (PConclusions: The full-ring CZT SPECT/CT system exhibited a higher CNR than the NaI(Tl) crystal-based system in the delay-phase scan of 99mTc-MIBI parathyroid imaging when using the thyroid and mediastinal blood pool as references. Additionally, it enables acquisition within a reduced time frame while maintaining comparable diagnostic sensitivity.
- Open Access
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e046081
Integration of Conventional and Radiomic Features From Fluorine‐18 Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging for Multimodal Prediction of Symptomatic Carotid Atherosclerotic Plaques
Background: The aim of this study was to evaluate an integrated fluorine‐18 fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (PET/MRI) model combining conventional and radiomic features for the noninvasive identification of symptomatic extracranial carotid atherosclerotic plaques. Methods: A total of 200 patients with advanced carotid plaques (78 symptomatic, 122 asymptomatic) underwent hybrid fluorine‐18 fluorodeoxyglucose PET/MRI. Six MRI morphological features (intraplaque hemorrhage, lipid‐rich necrotic core, ruptured fibrous cap, calcification, surface ulceration, and plaque enhancement) and 3 PET metabolic parameters—metabolic uptake, maximum standardized uptake value, and target‐to‐background ratio—were evaluated. A total of 1991 radiomics were extracted from each of the MRI and PET images, respectively. For each modality, 3 types of models were developed: conventional, radiomics, and combined (incorporating conventional and radiomic features). Diagnostic performance was evaluated using multivariate logistic regression and a linear support vector classifier. Results: In MRI‐based analysis, surface ulceration and plaque enhancement emerged as independent predictors of symptomatic plaques. In PET‐based analysis, standardized uptake value and metabolic uptake were identified as significant independent predictors. The PET conventional model outperformed the MRI conventional model in discriminative ability (areas under the curve: training, 0.899 versus 0.755; internal test, 0.926 versus 0.822; temporal validation, 0.878 versus 0.702). The integrated PET/MRI combined model achieved the best performance, with areas under the curve of 0.962 (training), 0.967 (internal test), and 0.926 (temporal validation), significantly outperforming PET‐ and MRI‐based combined models (all P <0.05). Conclusions: The fluorine‐18 fluorodeoxyglucose PET/MRI combined model integrating morphological, metabolic, and radiomic features outperformed other models, supporting its potential as a noninvasive, high‐precision tool for cerebrovascular risk stratification.
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e046081
Open AccessIntegration of Conventional and Radiomic Features From Fluorine‐18 Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging for Multimodal Prediction of Symptomatic Carotid Atherosclerotic Plaques
Background: The aim of this study was to evaluate an integrated fluorine‐18 fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (PET/MRI) model combining conventional and radiomic features for the noninvasive identification of symptomatic extracranial carotid atherosclerotic plaques. Methods: A total of 200 patients with advanced carotid plaques (78 symptomatic, 122 asymptomatic) underwent hybrid fluorine‐18 fluorodeoxyglucose PET/MRI. Six MRI morphological features (intraplaque hemorrhage, lipid‐rich necrotic core, ruptured fibrous cap, calcification, surface ulceration, and plaque enhancement) and 3 PET metabolic parameters—metabolic uptake, maximum standardized uptake value, and target‐to‐background ratio—were evaluated. A total of 1991 radiomics were extracted from each of the MRI and PET images, respectively. For each modality, 3 types of models were developed: conventional, radiomics, and combined (incorporating conventional and radiomic features). Diagnostic performance was evaluated using multivariate logistic regression and a linear support vector classifier. Results: In MRI‐based analysis, surface ulceration and plaque enhancement emerged as independent predictors of symptomatic plaques. In PET‐based analysis, standardized uptake value and metabolic uptake were identified as significant independent predictors. The PET conventional model outperformed the MRI conventional model in discriminative ability (areas under the curve: training, 0.899 versus 0.755; internal test, 0.926 versus 0.822; temporal validation, 0.878 versus 0.702). The integrated PET/MRI combined model achieved the best performance, with areas under the curve of 0.962 (training), 0.967 (internal test), and 0.926 (temporal validation), significantly outperforming PET‐ and MRI‐based combined models (all P <0.05). Conclusions: The fluorine‐18 fluorodeoxyglucose PET/MRI combined model integrating morphological, metabolic, and radiomic features outperformed other models, supporting its potential as a noninvasive, high‐precision tool for cerebrovascular risk stratification.
- Open Access
- 24 February 2026
- Published by Wiley in Exploration
- Vol. 6 (2)
Ultrasmall Au 10–12 Nanoclusters: A Novel Platform for 223 Ra‐Targeted Tumor α‐Therapy
223 Ra, a potent α‐emitting radionuclide, is currently limited to treating bone metastases in clinical practice. This constraint stems from the lack of stable chelating agents capable of withstanding its high recoil energy and the five decay daughters produced during decay, hindering its application in targeted α‐therapy (TAT). Ultrasmall gold nanoclusters (AuNCs) exhibit favorable pharmacokinetics, featuring tunable blood half‐life, renal clearance, and low hepatic/splenic sequestration. Given gold's high atomic number and structural flexibility, we hypothesized that AuNCs could encapsulate 223 Ra and its decay progeny, serving as an effective carrier for tumor TAT. Density functional theory simulations revealed that Au 10–12 nanoclusters, particularly a catenane‐structured Au 10 , could incorporate 223 Ra and its daughters with favorable energy dynamics. We then engineered α v β 3 ‐targeted AuNCs co‐labeled with 223 Ra and 68 Ga ( 68 Ga/ 223 Ra@AuNCs‐RGD). Molecular docking confirmed receptor specificity, while in vitro and in vivo studies demonstrated tumor‐specific targeting. PBPK modeling and Monte–Carlo simulations showed prolonged circulation ( t 1/2β = 139.4 min), renal clearance, sustained tumor retention, and efficient tumor energy deposition. The 68 Ga/ 223 Ra@AuNCs‐RGD platform achieved complete tumor regression and stimulated antitumor immunity, suggesting potential for TAT–immunotherapy synergy. This study establishes a theoretical foundation for stably doping 223 Ra into gold clusters and provides a framework for developing novel 223 Ra‐based α‐radiopharmaceuticals with significant clinical translation potential.
- 24 February 2026
- Published by Wiley in Exploration
- Vol. 6 (2)
Open AccessUltrasmall Au 10–12 Nanoclusters: A Novel Platform for 223 Ra‐Targeted Tumor α‐Therapy
223 Ra, a potent α‐emitting radionuclide, is currently limited to treating bone metastases in clinical practice. This constraint stems from the lack of stable chelating agents capable of withstanding its high recoil energy and the five decay daughters produced during decay, hindering its application in targeted α‐therapy (TAT). Ultrasmall gold nanoclusters (AuNCs) exhibit favorable pharmacokinetics, featuring tunable blood half‐life, renal clearance, and low hepatic/splenic sequestration. Given gold's high atomic number and structural flexibility, we hypothesized that AuNCs could encapsulate 223 Ra and its decay progeny, serving as an effective carrier for tumor TAT. Density functional theory simulations revealed that Au 10–12 nanoclusters, particularly a catenane‐structured Au 10 , could incorporate 223 Ra and its daughters with favorable energy dynamics. We then engineered α v β 3 ‐targeted AuNCs co‐labeled with 223 Ra and 68 Ga ( 68 Ga/ 223 Ra@AuNCs‐RGD). Molecular docking confirmed receptor specificity, while in vitro and in vivo studies demonstrated tumor‐specific targeting. PBPK modeling and Monte–Carlo simulations showed prolonged circulation ( t 1/2β = 139.4 min), renal clearance, sustained tumor retention, and efficient tumor energy deposition. The 68 Ga/ 223 Ra@AuNCs‐RGD platform achieved complete tumor regression and stimulated antitumor immunity, suggesting potential for TAT–immunotherapy synergy. This study establishes a theoretical foundation for stably doping 223 Ra into gold clusters and provides a framework for developing novel 223 Ra‐based α‐radiopharmaceuticals with significant clinical translation potential.